Glaxosmithkline

“Lucozade and Ribena are iconic brands that have made a huge contribution to GSK over the years, but now is the right time to sell them...

SOLD! GSK exits drinks market

Glaxo sells Lucozade and Ribena to Suntory for £1.35bn cash

By Shane STARLING

Ever-expanding Japanese beverage behemoth, Suntory, is the new owner of Lucozade and Ribena, which GlaxoSmithKline (GSK) has sold for £1.35bn (€1.6bn/$2.11bn) as it admits defeat in its internationalisation plans and trains its focus on its pharma activities.

'No easy solution' for Lucozade given its relative lack of global potential, according to one M&A expert

DISPATCHES FROM THE 2013 INNOBEV GLOBAL BEVERAGES CONGRESS, WARSAW, POLAND

GSK brand Lucozade unlikely to attract multinational trade buyer: M&A expert

By Ben BOUCKLEY

GSK brand Lucozade is more likely to attract a possible private equity buyer than a multinational food and beverage trade player that prefers brands with greater global potential, according to a top M&A expert.

ASA backed the energy shot's alertness claims despite 86 complaints

ASA backs Glaxo energy shot TV ad

By Shane Starling

The UK Advertising Standards Authority (ASA) has OK’d a television advert for a GlaxoSmithKline energy drink that claimed to boost alertness.

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers